Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 14, 2019
Total Value: $916M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 4,639,413 | $67.97M | 7.4% | — | — | COM | N5749R100 |
| CYTK | CYTOKINETICS INC | 5,176,878 | $58.24M | 6.4% | — | — | COM NEW | 23282W605 |
| — | ARRAY BIOPHARMA INC | 1,193,224 | $55.28M | 6.0% | — | — | COM | 04269X105 |
| ACIU | AC IMMUNE SA | 9,819,434 | $54.5M | 6.0% | — | — | SHS | H00263105 |
| — | MIRATI THERAPEUTICS INC | 527,253 | $54.31M | 5.9% | — | — | COM | 60468T105 |
| KURA | KURA ONCOLOGY INC | 2,204,119 | $43.4M | 4.7% | — | — | COM | 50127T109 |
| — | BLUEPRINT MEDICINES CORP | 437,565 | $41.28M | 4.5% | — | — | COM | 09627Y109 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 17,426,968 | $31.37M | 3.4% | — | — | COM | 45665G303 |
| RCUS | ARCUS BIOSCIENCES INC | 3,535,223 | $28.11M | 3.1% | — | — | COM | 03969F109 |
| — | MOLECULAR TEMPLATES INC | 3,256,515 | $27.19M | 3.0% | — | — | COM | 608550109 |
| XOMA | XOMA CORP DEL | 1,796,942 | $26.7M | 2.9% | — | — | COM NEW | 98419J206 |
| — | CALITHERA BIOSCIENCES INC | 6,750,482 | $26.33M | 2.9% | — | — | COM | 13089P101 |
| REPL | REPLIMUNE GROUP INC | 1,724,609 | $25.28M | 2.8% | — | — | COM | 76029N106 |
| CTMX | CYTOMX THERAPEUTICS INC | 1,873,617 | $21.02M | 2.3% | — | — | COM | 23284F105 |
| — | CONCERT PHARMACEUTICALS INC | 1,628,187 | $19.54M | 2.1% | — | — | COM | 206022105 |
| — | DICERNA PHARMACEUTICALS INC | 1,223,925 | $19.28M | 2.1% | — | — | COM | 253031108 |
| — | PIERIS PHARMACEUTICALS INC | 3,954,264 | $18.59M | 2.0% | — | — | COM | 720795103 |
| — | FIVE PRIME THERAPEUTICS INC | 3,003,342 | $18.11M | 2.0% | — | — | COM | 33830X104 |
| XENE | XENON PHARMACEUTICALS INC | 1,741,600 | $17.17M | 1.9% | — | — | COM | 98420N105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,764,784 | $16.43M | 1.8% | — | — | COM | 87164F105 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,505,429 | $14.99M | 1.6% | — | — | COM | 45166A102 |
| — | GALMED PHARMACEUTICALS LTD | 1,832,484 | $13.47M | 1.5% | — | — | SHS | M47238106 |
| — | CHEMOCENTRYX INC | 1,414,515 | $13.15M | 1.4% | — | — | COM | 16383L106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,063,802 | $12.88M | 1.4% | — | — | COM | 74366E102 |
| — | AKERO THERAPEUTICS INC | 648,348 | $12.42M | 1.4% | — | — | COM | 00973Y108 |
| ANAB | ANAPTYSBIO INC | 205,265 | $11.58M | 1.3% | — | — | COM | 032724106 |
| SPRO | SPERO THERAPEUTICS INC | 939,704 | $10.82M | 1.2% | — | — | COM | 84833T103 |
| CRVS | CORVUS PHARMACEUTICALS INC | 2,774,750 | $10.38M | 1.1% | — | — | COM | 221015100 |
| — | MERSANA THERAPEUTICS INC | 2,497,900 | $10.12M | 1.1% | — | — | COM | 59045L106 |
| — | VERASTEM INC | 6,328,994 | $9.557M | 1.0% | — | — | COM | 92337C104 |
| — | BIOLINERX LTD | 25,995,575 | $9.488M | 1.0% | — | — | SPONSORED ADS | 09071M106 |
| — | FORWARD PHARMA A/S | 8,480,079 | $8.734M | 1.0% | — | — | SPONSORED ADR | 34986J105 |
| — | X4 PHARMACEUTICALS INC | 580,500 | $8.708M | 1.0% | — | — | COM | 98420X103 |
| — | PREVAIL THERAPEUTICS INC | 656,483 | $8.666M | 0.9% | — | — | COM | 74140Y101 |
| — | ARQULE INC | 773,459 | $8.516M | 0.9% | — | — | COM | 04269E107 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 2,100,305 | $8.233M | 0.9% | — | — | COM NEW | 372427401 |
| — | EIGER BIOPHARMACEUTICALS INC | 675,000 | $7.155M | 0.8% | — | — | COM | 28249U105 |
| OVID | OVID THERAPEUTICS INC | 3,583,236 | $6.629M | 0.7% | — | — | COM | 690469101 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $5.955M | 0.7% | — | — | COM NEW | 12648L601 |
| — | MEI PHARMA INC | 2,221,272 | $5.553M | 0.6% | — | — | COM NEW | 55279B202 |
| — | GAMIDA CELL LTD | 1,000,000 | $5.08M | 0.6% | — | — | SHS | M47364100 |
| — | SUNESIS PHARMACEUTICALS INC | 6,770,425 | $4.921M | 0.5% | — | — | COM PAR | 867328700 |
| — | ALPINE IMMUNE SCIENCES INC | 1,151,717 | $4.849M | 0.5% | — | — | COM | 02083G100 |
| — | SPRING BK PHARMACEUTICALS INC | 1,301,701 | $4.803M | 0.5% | — | — | COM | 849431101 |
| — | ERYTECH PHARMA | 625,000 | $4.481M | 0.5% | — | — | SPONSORED ADR | 29604W108 |
| — | CIDARA THERAPEUTICS INC | 2,652,895 | $4.457M | 0.5% | — | — | COM | 171757107 |
| — | ESSA PHARMA INC | 1,329,700 | $3.085M | 0.3% | — | — | COM NEW | 29668H708 |
| — | SURFACE ONCOLOGY INC | 1,021,234 | $2.88M | 0.3% | — | — | COM | 86877M209 |
| — | REALM THERAPEUTICS PLC | 909,759 | $2.566M | 0.3% | — | — | SPONSORED ADS | 75606L103 |
| — | REGULUS THERAPEUTICS INC | 2,035,695 | $2.545M | 0.3% | — | — | COM NEW | 75915K200 |
| — | KARYOPHARM THERAPEUTICS INC | 355,266 | $2.128M | 0.2% | — | — | COM | 48576U106 |
| — | ALBIREO PHARMA INC | 65,500 | $2.112M | 0.2% | — | — | COM | 01345P106 |
| — | VICAL INC | 1,829,059 | $1.555M | 0.2% | — | — | COM NEW | 925602203 |
| MREO | MEREO BIOPHARMA GROUP PLC | 523,382 | $1.256M | 0.1% | — | — | ADS | 589492107 |
| — | CONTRAFECT CORP | 1,898,990 | $968K | 0.1% | — | — | COM | 212326102 |
| — | NOVUS THERAPEUTICS INC | 828,876 | $837K | 0.1% | — | — | COM | 67011N105 |